The safety and usefulness of high-dose-rate endoluminal brachytherapy as a boost in the treatment of patients with esophageal cancer with external beam radiation with or without chemotherapy

Conclusion: HDRBT is safe and beneficial for local control in the radical treatment of patients with esophageal cancer.